Archives
-
Cannabidiol in Orofacial Pain and Affective Deficits
2026-09-09
A 2026 Brain Research Bulletin study shows that cannabidiol can reduce inflammatory nociception while also improving anxiety-like, depression-like, and cognitive abnormalities in mouse models. Its major contribution is a multi-level mechanism linking peripheral CB2-related inflammatory control, central CB1-associated analgesic signaling, and normalization of serotonin dynamics in the central amygdala.
-
Trichostatin A (TSA): HDAC Workflow Guide
2026-09-09
Trichostatin A (TSA) converts HDAC inhibition into a practical probe for chromatin acetylation, cell-cycle control, differentiation, and cancer phenotypes. This guide combines dose planning, senescence-focused assay design, troubleshooting, and a careful translation of mitochondrial TERC research into epigenetic experiments.
-
CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer
2026-09-08
The reference study identifies Cdc2-like kinase 2 (CLK2) as a determinant of platinum resistance in ovarian cancer and links its activity to BRCA1-dependent DNA damage repair. Its tissue, cellular, mechanistic, and xenograft evidence supports CLK2 as a biologically testable target, while also defining important limits for pharmacological translation.
-
Polybrene: A Practical Guide to Viral Delivery
2026-09-08
Polybrene improves charge-dependent viral attachment and can rescue delivery in difficult-to-transduce cells, while its cytotoxicity profile makes dose and exposure optimization essential. This guide connects practical transduction controls with p53Y220C research, showing how better gene delivery can strengthen downstream pharmacology without being mistaken for a biological treatment effect.
-
BA1-S mRNA Prime–RBD Boosts Broad Neutralization
2026-09-07
Wang and colleagues identified a sequence-specific vaccination strategy in which an Omicron BA.1 spike mRNA prime was followed by two boosts with original-strain receptor-binding-domain mRNA. This regimen generated neutralizing activity across several Omicron subvariants and earlier variants of concern, offering a useful framework for rational mRNA vaccine development while highlighting the importance of antigen order.
-
OMV Delivery of mRNA Antigens for Tumor Vaccines
2026-09-07
The reference study developed engineered bacterial outer membrane vesicles (OMVs) that rapidly capture sequence-tagged mRNA antigens and deliver them to dendritic cells. By combining the RNA-binding protein L7Ae with the lysosomal escape protein listeriolysin O, the platform produced antitumor responses, including complete tumor regression in a subset of mice, while offering a flexible alternative to lipid nanoparticle formulation.
-
UTP Solution for Precision RNA Workflows
2026-09-05
See how a nuclease-free UTP Solution supports in vitro transcription, RNA amplification, siRNA synthesis, and quantitative assays inspired by new olfactory epigenetics research. Practical handling, concentration guidance, and troubleshooting help convert a 100 mM nucleotide stock into reproducible molecular biology workflows.
-
Tetramethylrhodamine ethyl ester perchlorate C8197
2026-09-04
Tetramethylrhodamine ethyl ester perchlorate (SKU: C8197) provides a practical live-cell readout of mitochondrial membrane potential for cytotoxicity, proliferation, and mitochondrial dysfunction studies. This scenario-based guide explains assay design, solvent controls, optimization, interpretation alongside ROS and apoptosis measurements, and evidence-conscious product selection.
-
GSK J4 HCl Workflows for JMJD3 Research
2026-09-04
GSK J4 HCl connects intracellular JMJD3 inhibition with practical assays for chromatin regulation, inflammatory signaling, and K27M glioma biology. This guide translates the decidual CXCL10 study into testable workflows while emphasizing controls, exposure design, and troubleshooting.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Assay Design
2026-09-03
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) converts mRNA delivery testing into a two-observable assay that separates cargo uptake from productive translation. This article shows how to use the reporter to de-risk targeted lipid nanoparticle studies, including HA-LNP platforms for transdermal cancer research.
-
Protease Inhibitor Cocktail for Plant m6A Assays
2026-09-03
Discover how a Protease Inhibitor Cocktail can improve plant cell protein stability when studying m6A-mediated antiviral mechanisms. This article connects extraction control, protein-complex assays, and the latest CMV–plant RNA research without confusing protein preservation with RNA modification measurement.
-
UTP Solution for Precise RNA Workflows
2026-09-02
UTP Solution (100 mM) provides a high-purity, nuclease-free uridine nucleotide for in vitro transcription, RNA amplification, and siRNA synthesis. This article connects practical stock handling and reaction design with the TRIM66 olfactory-receptor study, showing how reproducible RNA production can support mechanistic assays without overstating what the reference demonstrates.
-
Open-Platform DLP for 96-Well Hydrogel Printing
2026-09-02
The reference study introduces an open-platform digital light printer (OP-DLP) that combines programmable light projection with LabVIEW control for hydrogel fabrication and localized biomolecule activation in multiwell plates. Its demonstrations show reproducible thin hydrogel layers, customizable in-well patterns, and spatial de-caging of DNA without relying on manual gel transfer.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-01
Zhang et al. show that CDC42-dependent apical-basal polarity controls the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–Ereg–mTOR cascade that operates independently of canonical Wnt signaling. The study links epithelial architecture to crypt proliferation and provides a framework for separating polarity defects from downstream pathway effects in intestinal models.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Assay Design
2026-09-01
EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5 tracking with Firefly Luciferase expression in one 5-moUTP modified mRNA construct. This article presents an orthogonal assay strategy for separating delivery, intracellular fate, and translation rather than treating one reporter signal as a complete answer.